Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$334M |
| 2 |
GSK
GSK
|
+$231M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$188M |
| 4 |
Verizon
VZ
|
+$173M |
| 5 |
Mastercard
MA
|
+$159M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$840M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$520M |
| 5 |
Meta Platforms (Facebook)
META
|
+$426M |
Sector Composition
| 1 | Healthcare | 14.28% |
| 2 | Technology | 10.33% |
| 3 | Financials | 9.22% |
| 4 | Energy | 6.79% |
| 5 | Consumer Discretionary | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
ProShares UltraShort Euro
EUO
$33.6M
| $16K | ﹤0.01% |
+632
| New | +$16K |
|
3027
Gorman-Rupp
GRC
$1.13B
| $16K | ﹤0.01% |
561
-970
| -63% | -$27.7K |
|
3028
Heritage Financial
HFWA
$833M
| $16K | ﹤0.01% |
901
-3,219
| -78% | -$57.2K |
|
3029
HealthStream
HSTM
$855M
| $16K | ﹤0.01% |
636
-569
| -47% | -$14.3K |
|
3030
Interparfums
IPAR
$3.43B
| $16K | ﹤0.01% |
502
-849
| -63% | -$27.1K |
|
3031
Kforce
KFRC
$567M
| $16K | ﹤0.01% |
748
-1,267
| -63% | -$27.1K |
|
3032
Stride
LRN
$6.91B
| $16K | ﹤0.01% |
1,030
-1,494
| -59% | -$23.2K |
|
3033
Phibro Animal Health
PAHC
$1.61B
| $16K | ﹤0.01% |
442
-392
| -47% | -$14.2K |
|
3034
PDF Solutions
PDFS
$765M
| $16K | ﹤0.01% |
916
-1,563
| -63% | -$27.3K |
|
|
RGLS
3035
DELISTED
Regulus Therapeutics
RGLS
| $16K | ﹤0.01% |
9
-17
| -65% | -$30.2K |
|
3036
TriNet
TNET
$3.35B
| $16K | ﹤0.01% |
471
-12,905
| -96% | -$438K |
|
3037
Weis Markets
WMK
$1.75B
| $16K | ﹤0.01% |
330
-565
| -63% | -$27.4K |
|
3038
Waterstone Financial
WSBF
$275M
| $16K | ﹤0.01% |
1,330
-1,568
| -54% | -$18.9K |
|
|
ATRI
3039
DELISTED
Atrion Corp
ATRI
| $16K | ﹤0.01% |
45
-43
| -49% | -$15.3K |
|
|
PGTI
3040
DELISTED
PGT, Inc.
PGTI
| $16K | ﹤0.01% |
1,425
-2,412
| -63% | -$27.1K |
|
|
RUTH
3041
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $16K | ﹤0.01% |
1,086
-1,094
| -50% | -$16.1K |
|
|
OTIC
3042
DELISTED
Otonomy, Inc.
OTIC
| $16K | ﹤0.01% |
443
+34
| +8% | +$1.23K |
|
|
LDL
3043
DELISTED
Lydall, Inc.
LDL
| $16K | ﹤0.01% |
513
-1,017
| -66% | -$31.7K |
|
|
PRAH
3044
DELISTED
PRA Health Sciences, Inc.
PRAH
| $16K | ﹤0.01% |
585
-528
| -47% | -$14.4K |
|
|
IPHI
3045
DELISTED
INPHI CORPORATION
IPHI
| $16K | ﹤0.01% |
942
-3,541
| -79% | -$60.1K |
|
|
TOWR
3046
DELISTED
Tower International, Inc.
TOWR
| $16K | ﹤0.01% |
619
-2,284
| -79% | -$59K |
|
|
GNCMA
3047
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $16K | ﹤0.01% |
1,080
-8,166
| -88% | -$121K |
|
|
SCMP
3048
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $16K | ﹤0.01% |
1,073
-3,167
| -75% | -$47.2K |
|
|
GIMO
3049
DELISTED
Gigamon Inc.
GIMO
| $16K | ﹤0.01% |
730
-10,284
| -93% | -$225K |
|
|
BDBD
3050
DELISTED
BOULDER BRANDS INC
BDBD
| $16K | ﹤0.01% |
1,830
-1,638
| -47% | -$14.3K |
|